Primrose Bio closes growth financing round led by Signet
Primrose Bio, Inc. closed a growth financing round led by Signet Healthcare Partners, with participation from 1315 Capital, Ligand Pharmaceuticals, LDV Partners and Agent Capital. James Gale of Signet joined Primrose’s board.